markets

Cardinal Health Declares Quarterly Dividend of $0.5158 Per Share

Summarized from All Financial Services & Investing

Cardinal Health's board approved a $0.5158 quarterly dividend payable Jan. 15, 2027, to shareholders of record.

Cardinal Health Declares Quarterly Dividend of $0.5158 Per Share

Cardinal Health (NYSE: CAH) announced Monday that its board of directors has approved a quarterly cash dividend of $0.5158 per share, to be paid out of the company's capital surplus, the Dublin, Ohio-based healthcare distributor said in a statement.

The dividend is scheduled to be payable on January 15, 2027, to shareholders of record as of a date to be determined. The declaration continues the company's established pattern of returning capital to investors through regular quarterly distributions.

Read more 2x Long Anthropic ETF Launches as ANT Debuts on Nasdaq →

Cardinal Health ranks among the largest healthcare services and pharmaceutical distribution companies in the United States, supplying drugs, medical products, and related services to hospitals, pharmacies, and other healthcare providers nationwide. Dividend announcements of this nature are typically viewed by analysts as a signal of management's confidence in near-term cash flow stability.

The payment source — designated as capital surplus rather than retained earnings — is a technical accounting distinction that carries no immediate operational significance for most shareholders but may be relevant for certain institutional or tax-reporting purposes.

Continue reading at All Financial Services & Investing.

Frequently Asked Questions

Q.How much is Cardinal Health's quarterly dividend per share?

Cardinal Health's board approved a quarterly dividend of $0.5158 per share.

Q.When will Cardinal Health pay its next dividend?

The dividend is scheduled to be payable on January 15, 2027, to shareholders of record.

Q.Where does Cardinal Health's dividend payment come from?

The dividend will be paid out of the company's capital surplus, as specified in the board's approval.

More in markets →